JP5315051B2 - オロパタジンを含む眼科用経皮吸収型製剤 - Google Patents

オロパタジンを含む眼科用経皮吸収型製剤 Download PDF

Info

Publication number
JP5315051B2
JP5315051B2 JP2008520121A JP2008520121A JP5315051B2 JP 5315051 B2 JP5315051 B2 JP 5315051B2 JP 2008520121 A JP2008520121 A JP 2008520121A JP 2008520121 A JP2008520121 A JP 2008520121A JP 5315051 B2 JP5315051 B2 JP 5315051B2
Authority
JP
Japan
Prior art keywords
olopatadine
acid
preparation
salt
patch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2008520121A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009500398A (ja
JP2009500398A5 (cg-RX-API-DMAC7.html
Inventor
明治 礒脇
朋子 中嶋
聡 大鳥
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Publication of JP2009500398A publication Critical patent/JP2009500398A/ja
Publication of JP2009500398A5 publication Critical patent/JP2009500398A5/ja
Application granted granted Critical
Publication of JP5315051B2 publication Critical patent/JP5315051B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2008520121A 2005-07-08 2006-07-07 オロパタジンを含む眼科用経皮吸収型製剤 Expired - Fee Related JP5315051B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69736805P 2005-07-08 2005-07-08
US60/697,368 2005-07-08
PCT/JP2006/314017 WO2007007863A1 (en) 2005-07-08 2006-07-07 Percutaneously absorptive ophthalmic preparation comprising olopatadine

Publications (3)

Publication Number Publication Date
JP2009500398A JP2009500398A (ja) 2009-01-08
JP2009500398A5 JP2009500398A5 (cg-RX-API-DMAC7.html) 2009-08-20
JP5315051B2 true JP5315051B2 (ja) 2013-10-16

Family

ID=37022903

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008520121A Expired - Fee Related JP5315051B2 (ja) 2005-07-08 2006-07-07 オロパタジンを含む眼科用経皮吸収型製剤

Country Status (7)

Country Link
US (1) US8101654B2 (cg-RX-API-DMAC7.html)
EP (1) EP1901708B1 (cg-RX-API-DMAC7.html)
JP (1) JP5315051B2 (cg-RX-API-DMAC7.html)
KR (1) KR20080038335A (cg-RX-API-DMAC7.html)
CN (1) CN101217937A (cg-RX-API-DMAC7.html)
ES (1) ES2437077T3 (cg-RX-API-DMAC7.html)
WO (1) WO2007007863A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050092429A (ko) * 2003-01-22 2005-09-21 니찌방 가부시기가이샤 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환치료약의 눈의 국소 조직으로의 이행 방법
US20090143359A1 (en) * 2005-07-08 2009-06-04 Akiharu Isowaki Percutaneously Absorptive Ophthalmic Preparation Comprising Epinastine
US20090318422A1 (en) * 2006-08-28 2009-12-24 Akiharu Isowaki Ophthalmic percutaneous absorption type preparation
ES2752008T3 (es) * 2009-10-30 2020-04-02 Intratus Inc Métodos y composiciones para la liberación sostenida de fármacos
US8900626B2 (en) 2011-06-20 2014-12-02 Senju Usa, Inc. Transdermal drug delivery system and method of using the same
EP3827823A1 (en) * 2012-12-19 2021-06-02 Novartis AG Lfa-1 inhibitor formulations
WO2016182032A1 (ja) * 2015-05-12 2016-11-17 参天製薬株式会社 アゾール系抗真菌薬の眼瞼皮膚への投与
CN106324111A (zh) * 2015-06-24 2017-01-11 江苏吉贝尔药业股份有限公司 一种盐酸奥洛他定滴眼液的检测方法
TWI825013B (zh) * 2017-04-19 2023-12-11 日商帝國製藥股份有限公司 含有盧帕他定(rupatadine)之貼附劑
CN107823124B (zh) * 2017-11-09 2018-11-27 广州博济医药生物技术股份有限公司 一种盐酸奥洛他定外用组合物及其乳膏剂

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6310784A (ja) * 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
US5641805A (en) * 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
US5744151A (en) * 1995-06-30 1998-04-28 Capelli; Christopher C. Silver-based pharmaceutical compositions
JPH09194396A (ja) * 1996-01-17 1997-07-29 Pola Chem Ind Inc 貼付剤用マトリックス
DK1187617T3 (da) * 1999-06-18 2004-04-13 Alcon Mfg Ltd Fremgangsmåde til at vælge koncentrationen af et amfipatisk antihistaminlægemiddel ved at bestemme lægemidlets overfladeaktivitetsmåltal
CA2379147C (en) * 1999-07-15 2009-09-01 Hisamitsu Pharmaceutical Co., Inc. Percutaneously absorbable preparations
JP4653893B2 (ja) * 2000-01-27 2011-03-16 純一 須藤 二層型経皮吸収製剤
TWI231759B (en) 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
KR20050092429A (ko) * 2003-01-22 2005-09-21 니찌방 가부시기가이샤 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환치료약의 눈의 국소 조직으로의 이행 방법

Also Published As

Publication number Publication date
US8101654B2 (en) 2012-01-24
ES2437077T3 (es) 2014-01-08
EP1901708A1 (en) 2008-03-26
WO2007007863A1 (en) 2007-01-18
US20090209632A1 (en) 2009-08-20
JP2009500398A (ja) 2009-01-08
KR20080038335A (ko) 2008-05-06
CN101217937A (zh) 2008-07-09
EP1901708B1 (en) 2013-09-11

Similar Documents

Publication Publication Date Title
JP4629578B2 (ja) 眼疾患治療用経皮吸収型製剤
JP5020061B2 (ja) 経皮吸収型製剤
US20090318422A1 (en) Ophthalmic percutaneous absorption type preparation
JP5248040B2 (ja) 5−メチル−1−フェニル−2−(1h)−ピリドン含有貼付剤
EP2493474A2 (en) Methods and compositions for sustained delivery of drugs
JP2009500398A (ja) オロパタジンを含む眼科用経皮吸収型製剤
JP4308255B2 (ja) ムスカリン受容体作動薬を含有する眼科用経皮吸収型製剤
JP2009500397A (ja) エピナスチンを含む眼科用経皮吸収型製剤
JPH08509716A (ja) ピロカルピンの制御放出システム
US20090005319A1 (en) Topical compositions for delaying ejaculation and methods of using the same
JP6459148B2 (ja) 経皮吸収型製剤
US20250000814A1 (en) Percutaneous absorption preparation for treating dementia comprising memantine enanthate
JP6729584B2 (ja) 経皮吸収型貼付剤
US20210369636A1 (en) Lidocaine-Containing Patch
KR20070018755A (ko) 무스카린 수용체 작동약을 함유한 안과용 경피흡수형 제제
JP7352283B2 (ja) クエン酸フェンタニル含有経皮吸収製剤
WO2017057541A1 (ja) 経皮吸収型製剤
WO2007013661A1 (ja) 眼科用経皮吸収型製剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090703

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090703

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120417

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120615

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120710

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120907

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130205

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130408

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130611

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130708

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 5315051

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees